Kura Oncology Ownership | Who Owns Kura Oncology?
Kura Oncology Ownership Summary
Kura Oncology is owned by 98.78% institutional investors, 1.43% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.86% of KURA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.41% of its assets in Kura Oncology shares.
KURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kura Oncology | 98.78% | 1.43% | -0.21% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 10.51M | 11.86% | $115.29M |
| Suvretta capital management | 8.58M | 9.68% | $94.07M |
| Bvf inc/il | 8.45M | 9.53% | $92.65M |
| Blackrock | 6.97M | 8.30% | $143.43M |
| Vanguard group | 5.51M | 6.28% | $57.22M |
| State street | 5.33M | 6.01% | $58.46M |
| Vanguard capital management | 3.92M | 4.42% | $42.96M |
| Armistice capital | 3.68M | 4.15% | $40.35M |
| Aqr capital management | 3.13M | 3.53% | $34.30M |
| Goldman sachs group | 2.27M | 2.56% | $24.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alethea capital management | 2.17M | 9.85% | $23.78M |
| Prosight management, lp | 2.02M | 3.82% | $22.18M |
| Ally bridge group (ny) | 290.00K | 2.81% | $3.18M |
| Lion point capital, lp | 46.00K | 2.41% | $504.62K |
| Bvf inc/il | 8.45M | 2.37% | $92.65M |
| Suvretta capital management | 8.58M | 1.72% | $94.07M |
| 1492 capital management | 467.15K | 1.51% | $5.12M |
| Nan fung trinity (hk) | 1.17M | 1.27% | $12.89M |
| Boxer capital | 1.00M | 1.08% | $20.59M |
| Sector gamma as | 433.01K | 1.03% | $4.75M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.41M | 0.01% | 1.41M |
| Aqr capital management | 3.13M | 0.01% | 1.00M |
| Blackrock funding, inc. /de | 10.51M | 0.00% | 871.70K |
| Goldman sachs group | 2.27M | 0.00% | 831.70K |
| State street | 5.33M | 0.00% | 817.32K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -5.41M |
| Paradigm biocapital advisors lp | - | - | -4.33M |
| Ra capital management | - | - | -4.00M |
| Ecor1 capital | 872.50K | 0.37% | -3.33M |
| Avoro capital advisors | - | - | -2.25M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arrowstreet capital, limited partnership | 1.41M | 0.01% | 1.41M | $15.47M |
| Sixth street partners management company | 676.40K | 0.00% | 676.40K | $7.42M |
| Royce & associates lp | 609.99K | 0.05% | 609.99K | $6.69M |
| Jupiter asset management | 509.89K | 0.03% | 509.89K | $5.59M |
| Ally bridge group (ny) | 290.00K | 2.81% | 290.00K | $3.18M |
Sold Out
| Holder | Change |
|---|---|
| Wealthspire advisors | -10.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Advisory services network | -14.00 |
| Principal securities | -18.00 |
| Main street group | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 225 | -1.32% | 87,530,151 | 3.68% | 98 | 1.09% | 122 | 15.09% | 62 | -24.39% |
| Mar 31, 2026 | 122 | -44.55% | 29,094,977 | -65.91% | 33 | 0.35% | 62 | -53.73% | 40 | -21.57% |
| Dec 31, 2025 | 155 | -25.12% | 49,542,038 | -40.99% | 56 | 0.62% | 92 | -22.69% | 38 | -26.92% |
| Sep 30, 2025 | 197 | 7.07% | 77,024,381 | -6.25% | 87 | 1.00% | 112 | -0.89% | 50 | 16.28% |
| Jun 30, 2025 | 183 | -2.14% | 82,143,917 | 5.53% | 93 | 1.18% | 112 | 16.67% | 43 | -24.56% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.03M | 3.41% | 6.95K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.80M | 3.15% | 165.40K |
| Vanguard Total Stock Mkt Idx Inv | 2.80M | 3.15% | 165.40K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.80M | 3.15% | - |
| Vanguard US Total Market Shares ETF | 2.17M | 2.68% | 3.54K |
| iShares Russell 2000 ETF | 2.17M | 2.44% | -38.50K |
| HBM Healthcare Investments AG Ord | 1.79M | 2.01% | - |
| SPDR® S&P Biotech ETF | 1.28M | 1.48% | 2.86K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.03M | 1.16% | 2.21K |
| Invesco MSCI World ETF | 897.58K | 1.03% | 897.58K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | $51.66K |
| Aug 24, 2026 | WILSON TROY EDWARD | President and CEO | Buy | $1.24M |
| Aug 19, 2026 | Bair Teresa Brophy | Chief Legal Officer | Sell | $397.68K |
| Aug 17, 2026 | WILSON TROY EDWARD | President and CEO | Buy | $1.11M |
| Jun 18, 2026 | Leoni Mollie | Chief Medical Officer | Sell | $834.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 2 | 2 |
| 2026 Q2 | - | 5 |
| 2026 Q1 | - | 16 |
| 2025 Q4 | - | 7 |
| 2025 Q3 | 3 | 6 |
KURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools